HySum Flexibles Global, Inc (300501) Fair Value & Analysis
Consumer Cyclical · CN · Market cap 3.6B CNY
Fair value as of: Jun 24, 2026
Analysis
HySum Flexibles Global, Inc (300501) currently trades at ¥14.70, while our model-based Fair Value estimate is ¥16.81 — implying the stock looks roughly 14.4% undervalued today. We read business quality at 87/100 (high quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
HySum Flexibles Global, Inc. engages in the manufacture, sale, and export of pharmaceutical packaging products in China and internationally. The company offers pharmaceutical packaging products, including cold-form, tropical blister foil, PVC/Aclar sheets, PTP lidding, hipack child-resistant packaging, hipack AL/PE strip packs, hipack complex laminated flexible films, lamination foil and pouch, composite films, hipack AL/PE suppository laminates, PVC, PVDC/PVC pharmaceutical packaging, PE series bags, and PP, PE, and COP bottles; and food packaging, comprising three-layer co-extruded PE films, top-blown and bottom-blown multi-layer co-extruded high barrier films, and multi-layer co-extruded sheets. It also provides new energy material packaging, such as aluminum plastic films; precision injection packaging comprising precision injection molded packaging, desiccant combination, precision dosing devices, diagnostic reagent package, and high-barrier vials. The company was formerly know…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is HySum Flexibles Global, Inc (300501) undervalued?
What is the fair value of 300501?
What is the quality score of 300501?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.